1. Home
  2. AMPH vs JCAP Comparison

AMPH vs JCAP Comparison

Compare AMPH & JCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • JCAP
  • Stock Information
  • Founded
  • AMPH 1996
  • JCAP 2002
  • Country
  • AMPH United States
  • JCAP United States
  • Employees
  • AMPH N/A
  • JCAP N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • JCAP
  • Sector
  • AMPH Health Care
  • JCAP
  • Exchange
  • AMPH Nasdaq
  • JCAP NYSE
  • Market Cap
  • AMPH 1.1B
  • JCAP 1.2B
  • IPO Year
  • AMPH 2014
  • JCAP 2025
  • Fundamental
  • Price
  • AMPH $21.67
  • JCAP $16.43
  • Analyst Decision
  • AMPH Hold
  • JCAP Strong Buy
  • Analyst Count
  • AMPH 5
  • JCAP 5
  • Target Price
  • AMPH $38.00
  • JCAP $23.40
  • AVG Volume (30 Days)
  • AMPH 462.5K
  • JCAP 192.9K
  • Earning Date
  • AMPH 08-07-2025
  • JCAP 01-01-0001
  • Dividend Yield
  • AMPH N/A
  • JCAP N/A
  • EPS Growth
  • AMPH N/A
  • JCAP N/A
  • EPS
  • AMPH 2.77
  • JCAP N/A
  • Revenue
  • AMPH $730,659,000.00
  • JCAP $485,042,000.00
  • Revenue This Year
  • AMPH $0.92
  • JCAP N/A
  • Revenue Next Year
  • AMPH $5.55
  • JCAP N/A
  • P/E Ratio
  • AMPH $7.84
  • JCAP $6.71
  • Revenue Growth
  • AMPH 8.05
  • JCAP 29.09
  • 52 Week Low
  • AMPH $20.43
  • JCAP $16.28
  • 52 Week High
  • AMPH $53.96
  • JCAP $19.55
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 41.15
  • JCAP N/A
  • Support Level
  • AMPH $20.43
  • JCAP N/A
  • Resistance Level
  • AMPH $22.90
  • JCAP N/A
  • Average True Range (ATR)
  • AMPH 0.73
  • JCAP 0.00
  • MACD
  • AMPH 0.15
  • JCAP 0.00
  • Stochastic Oscillator
  • AMPH 50.20
  • JCAP 0.00

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About JCAP JEFFERSON CAPITAL INC

Jefferson Capital Inc is a analytically driven purchaser and manager of charged-off and insolvency consumer accounts with operations in the United States, Canada, the United Kingdom and Latin America. Its accounts purchase are the unpaid obligations of individuals owed to credit grantors, which include banks, non-bank consumer lenders, auto finance companies, utilities and telecom companies.

Share on Social Networks: